Page 53 - GPD-3-3
P. 53
Gene & Protein in Disease Phage therapy for Mycobacterium infections
79. Diacon AH, Guerrero-Bustamante CA, Rosenkranz B, 90. Dunne M, Hupfeld M, Klumpp J, Loessner MJ. Molecular
Rubio Pomar FJ, Vanker N, Hatfull GF. Mycobacteriophages basis of bacterial host interactions by gram-positive
to treat tuberculosis: Dream or delusion? Respiration. targeting bacteriophages. Viruses. 2018;10(8):397.
2022;101(1):1-15.
doi: 10.3390/v10080397
doi: 10.1159/000519870
91. Johansen MD, Alcaraz M, Dedrick RM, et al.
80. Guerrero-Bustamante CA, Dedrick RM, Garlena RA, Mycobacteriophage-antibiotic therapy promotes enhanced
Russell DA, Hatfull GF. Toward a phage Cocktail for clearance of drug-resistant Mycobacterium abscessus. Dis
tuberculosis: Susceptibility and tuberculocidal action Model Mech. 2021;14(9):dmm049159.
of mycobacteriophages against diverse Mycobacterium
tuberculosis strains. mBio. 2021;12(3):e00973-21. doi: 10.1242/dmm.049159
92. Senhaji-Kacha A, Esteban J, Garcia-Quintanilla M.
doi: 10.1128/mBio.00973-21
Considerations for phage therapy against Mycobacterium
81. Myers JA. Can tuberculosis be eradicated? Dis Chest. abscessus. Front Microbiol. 2020;11:609017.
1963;43:327-329.
doi: 10.3389/fmicb.2020.609017
doi: 10.1378/chest.43.3.327
93. Li Q, Zhou M, Fan X, Yan J, Li W, Xie J. Mycobacteriophage
82. Fish W. Presidential address to preventive medicine section. SWU1 gp39 can potentiate multiple antibiotics against
R Soc Health J. 1957;77(7):340-343. Mycobacterium via altering the cell wall permeability. Sci
doi: 10.1177/146642405707700704 Rep. 2016;6:28701.
83. Wulandari DA, Hartati YW, Ibrahim AU, Pitaloka DAE, doi: 10.1038/srep28701
Irkham. Multidrug-resistant tuberculosis. Clin Chim Acta. 94. Hatfull GF. Phage Therapy for nontuberculous mycobacteria:
2024;559:119701. Challenges and opportunities. Pulm Ther. 2023;9(1):91-107.
doi: 10.1016/j.cca.2024.119701 doi: 10.1007/s41030-022-00210-y
84. Velayati AA, Masjedi MR, Farnia P, et al. Emergence of new 95. Dedrick RM, Smith BE, Cristinziano M, et al. Phage therapy
forms of totally drug-resistant tuberculosis bacilli: Super of Mycobacterium infections: Compassionate use of phages
extensively drug-resistant tuberculosis or totally drug- in 20 patients with drug-resistant mycobacterial disease.
resistant strains in Iran. Chest. 2009;136(2):420-425. Clin Infect Dis. 2023;76(1):103-112.
doi: 10.1378/chest.08-2427 doi: 10.1093/cid/ciac453
85. Lange C, Abubakar I, Alffenaar JW, et al. Management of 96. Dedrick RM, Freeman KG, Nguyen JA, et al. Potent antibody-
patients with multidrug-resistant/extensively drug-resistant mediated neutralization limits bacteriophage treatment of
tuberculosis in Europe: A TBNET consensus statement. Eur a pulmonary Mycobacterium abscessus infection. Nat Med.
Respir J. 2014;44(1):23-63. 2021;27(8):1357-1361.
doi: 10.1183/09031936.00188313 doi: 10.1038/s41591-021-01403-9
86. Hatfull GF, Dedrick RM, Schooley RT. Phage therapy for 97. Secor PR, Dandekar AA. More than simple parasites: The
antibiotic-resistant bacterial infections. Annu Rev Med. sociobiology of bacteriophages and their bacterial hosts.
2022;73:197-211. mBio. 2020;11(2):e00041-20.
doi: 10.1146/annurev-med-080219-122208
doi: 10.1128/mBio.00041-20
87. Li P, Yong-Ai L, Baowen C, Youlun L, Xiaobing S, 98. Mushegian AR. Are there 10 virus particles on earth, or
31
Guo-Zhi W. Effect of bacteriophage D29 on the immune more, or fewer? J Bacteriol. 2020;202(9):e00052-20.
function of guinea pigs with a model of tuberculosis. Her
Med. 2006;0723:767-770. doi: 10.1128/jb.00052-20
88. Gan Y, Liu P, Wu T, Guo S. Different characteristics between 99. Hendrix RW, Smith MC, Burns RN, Ford ME, Hatfull GF.
mycobacteriophage Chy1 and D29, which were classified Evolutionary relationships among diverse bacteriophages
as cluster A2 mycobacteriophages. Indian J Med Microbiol. and prophages: All the world’s a phage. Proc Natl Acad Sci
2016;34(2):186-192. U S A. 1999;96(5):2192-2197.
doi: 10.4103/0255-0857.180282 doi: 10.1073/pnas.96.5.2192
89. Gan Y, Wu T, Liu P, Guo S. Characterization and classification 100. Hanauer DI, Jacobs-Sera D, Pedulla ML, Cresawn SG,
of Bo4 as a cluster G mycobacteriophage that can infect and Hendrix RW, Hatfull GF. Inquiry learning. Teaching
lyse M. tuberculosis. Arch Microbiol. 2014;196(3):209-218. scientific inquiry. Science. 2006;314(5807):1880-1881.
doi: 10.1007/s00203-014-0954-6 doi: 10.1126/science.1136796
Volume 3 Issue 3 (2024) 14 doi: 10.36922/gpd.2935

